Ratings by Truist Securities (Les Sulewski)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2026 | Viatris | VTRS | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2026 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2026 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2026 | Vanda Pharmaceuticals | VNDA | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2026 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Viatris | VTRS | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2026 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2026 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2026 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2025 | Viatris | VTRS | New Coverage | Buy (N/A) |
9.93 (16.07) |
61.83% | Details | |
| 9/23/2025 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | Teva Pharma | TEVA | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2025 | Pacira Pharmaceuticals | PCRX | Upgrade | Hold (N/A) |
21.82 (24.07) |
10.31% | Details | |
| 6/24/2025 | CorMedix | CRMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2025 | Teva Pharma | TEVA | New Coverage | Buy (N/A) |
16.96 (33.73) |
98.88% | Details | |
| 4/8/2025 | Pacira Pharmaceuticals | PCRX | Maintain | Hold (N/A) |
|
Details | ||
| 1/30/2025 | Pacira Pharmaceuticals | PCRX | Upgrade | Buy (Hold) |
26.03 (21.82) |
-16.17% | Details | |
| 10/2/2024 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2024 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Pacira Pharmaceuticals | PCRX | Downgrade | Sell (Buy) |
12.29 (26.03) |
111.8% | Details | |
| 8/12/2024 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2024 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2024 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Buy (N/A) |
|
Details |
